Chronic Disease
Featured Topics
Lead story
Other featured articles
-
Reductions in Mid-Life Diabetes, Hypertension Increase Future Number of Americans with Dementia
Improving cardiovascular health at middle and older ages is not enough to slow the growth in the number of older Americans with dementia, further underscoring the need for innovations that will delay or prevent dementia.
Posted in -
New Payment Strategy Could Help States Treat More Hepatitis C Patients While Encouraging Innovation
A curative treatment exists for chronic hepatitis C infection, yet many Medicaid beneficiaries do not have access to these drugs. Neeraj Sood and his colleagues have developed a novel pricing strategy to expand access.
-
NAFTA Talks’ Potential Diabetes Threat
U.S. proposals to restrict junk food warnings will adversely affect the health of citizens in 3 countries writes Goldman and Gonzalez Gonzales in U.S. News
Posted in -
NIH Awards USC School of Pharmacy, Price School of Public Policy 5-Year Grant to Support Minority Aging Research in Schaeffer Center
The $2.7 million award funds scholars pursuing research in health disparities in aging with an emphasis on Alzheimer’s disease.
Posted in
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
Mortality Risk, Insurance, and the Value of Life
People with shorter life expectancies place more value on increases in survival than people who anticipate longer life spans.
Categorized in -
The Association of Multiple Anti-Hypertensive Medication Classes with Alzheimer’s Disease Incidence Across Sex, Race, and Ethnicity
The researchers find hypertension management treatments that include RAS-acting ARBs may, in addition to lowering blood pressure, reduce AD risk, particularly for white and black women and white men.
-
Some Blood Pressure Medications May Reduce Risk of Alzheimer’s, But Not For All Populations
Certain antihypertensive medications may prevent the onset of the disease, but only among black and white women and white men.
-
Proposition 3 Could Provide New Resources for Utahns with Diabetes
An overlooked factor in the debate over Proposition 3 is the impact that an expansion of Utah’s Medicaid program would have on the state’s diabetes epidemic, argues Rebecca Myerson in an op-ed in the Salt Lake Tribune.
Categorized in -
Racial and Ethnic Differences in Trends in Dementia Prevalence and Risk Factors in the United States
The researchers find disparities in dementia prevalence declined between blacks and whites and increased between Hispanics and whites.
-
Mortality Risk, Insurance, and the Value of Life
In a working paper submitted to the National Bureau of Economic Research, Darius Lakdawalla found mortality improvement may be worth more, not less, to patients facing shorter lives.
Categorized in